The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Related News Articles

Headline
HHS’ Health Sector Cybersecurity Coordination Center urged health care organizations to install patches to protect their Windows systems against DejaBlue.
Headline
The Healthcare Sector Coordinating Council, a public-private partnership of health care companies and providers developing collaborative solutions to mitigate…
Headline
The AHA and the Department of Homeland Security July 17 at 1 p.m. ET will host a webinar discussing current cybersecurity threats to the health care sector.
Headline
The AHA and the Department of Homeland Security July 17 at 1 p.m. ET will host a webinar discussing current cybersecurity threats to the health care sector.
Headline
Medtronic has recalled certain MiniMed insulin pumps due to cybersecurity risks, and will provide alternative pumps to the estimated 4,000 U.S. patients using…
Headline
Hospitals spend close to $360 million each year to manage drug shortages, according to a study released this week by Vizient Inc.